Stock Price Quote

VENKAT PHARMA LTD.

NSE : NABSE : 532093ISIN CODE : INE346F01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE3.400 (0 %)
PREV CLOSE ( ) 3.40
OPEN PRICE ( ) 3.72
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 105
TODAY'S LOW / HIGH ( )3.40 3.72
52 WK LOW / HIGH ( ) 3.43.72
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1989
Management Info
A Ramkrishna - Chairman Saila Babu - Managing Director
Registered Office

Address B - 4, President Banjara Road, 2 Banjara Hills,
Hyderabad,
Andhra Pradesh-500034

Phone 040- 23355399

Email --

Website www.venkatpharmaltd.com

Registrars Details
Bigshare Services Pvt Ltd
G 10 Left Wing Amruta Village , Opp: Yashoda Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE

NEWS

18Sep Venkat Pharma Fixes Book Closure for A
Venkat Pharma has informed that the Register of Members & Share Tran..
12Sep Venkat Pharma informs about Financial
Venkat Pharma has informed about the Standalone Financial Results &..
18Jun Venkat Pharma informs about standalone
Venkat Pharma has informed about the Standalone Financial Results &..
05Feb Venkat Pharma informs about financial
Venkat Pharma has informed about the Financial Results & a copy of t..
20Nov Venkat Pharma informs about financial
Venkat Pharma has informed about the Financial Results & a copy of t..

Financials

in Millions
QTR Dec 14 ANNUAL 14
Net Profit-0.01-0.15
Gross Profit -0.01 -0.15
Operating Profit -0.01-0.15
Net Sales 0

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  6838.70 (5.00%)
M.Cap ( in Cr)15749.95
Astrazeneca Pharma I (BSE)
peergroup  6481.40 (2.05%)
M.Cap ( in Cr)16301.25
NGL Fine-Chem (BSE)
peergroup  2405.00 (2.99%)
M.Cap ( in Cr)1477.66
Strides Pharma Scien (BSE)
peergroup  984.50 (4.50%)
M.Cap ( in Cr)9094.24
Mercury Laboratories (BSE)
peergroup  975.00 (4.19%)
M.Cap ( in Cr)114.48

Shareholding Pattern

NON-INSTITUTION 77.65%
PROMOTERS 22.35%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Venkat Pharma Ltd.

Venkat Pharma Ltd. was incorporated in the year 1989. Its today's share price is 3.4. Its current market capitalisation stands at Rs 1.7 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0 Cr. The company's management includes Saila Babu, A Ramkrishna, M Ranga Rao.

It is listed on the BSE with a BSE Code of 532093 , NSE with an NSE Symbol of and ISIN of INE346F01018. It's Registered office is at B - 4, President Banjara Road, 2 Banjara HillsHyderabad-500034, Andhra Pradesh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Mahesh Virender & Sriram, RV Chalam

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.